Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Eur J Pharm Sci ; 126: 33-48, 2019 Jan 01.
Article in English | MEDLINE | ID: mdl-29933075

ABSTRACT

This paper investigates the safety of a novel 'magnetic injection' method of delivering therapy to the cochlea, in a rodent model. In this method of administration, a magnetic field is employed to actively transport drug-eluting superparamagnetic iron-oxide core nanoparticles into the cochlea, where they then release their drug payload (we delivered the steroid prednisolone). Our study design and selection of control groups was based on published regulatory guidance for safety studies that involve local drug delivery. We tested for both single and multiple delivery doses to the cochlea, and found that magnetic delivery did not harm hearing. There was no statistical difference in hearing between magnetically treated ears versus ears that received intra-tympanic steroid (a mimic of a standard-of-care for sudden sensorineural hearing loss), both 2 and 30 days after treatment. Since our treatment is local to the ear, the levels of steroid and iron circulating systemically after our treatment were low, below mass-spectrometry detection limits for the steroid and no different from normal for iron. No adverse findings were observed in ear tissue histopathology or in animal gross behavior. At 2 and 30 days after treatment, inflammatory changes examined in the ear were limited to the middle ear, were very mild in severity, and by day 90 there was ongoing and almost complete reversibility of these changes. There were no ear tissue scarring or hemorrhage trends associated with magnetic delivery. In summary, after conducting a pre-clinical safety study, no adverse safety issues were observed.


Subject(s)
Cochlea , Magnetite Nanoparticles/chemistry , Prednisolone/toxicity , Animals , Behavior, Animal/drug effects , Drug Delivery Systems , Drug Liberation , Ear, Inner/drug effects , Ear, Inner/pathology , Humans , Inflammation/chemically induced , Inflammation/pathology , Injections , Male , Prednisolone/administration & dosage , Rats, Long-Evans
2.
J Neurosurg ; 94(5): 706-11, 2001 May.
Article in English | MEDLINE | ID: mdl-11354400

ABSTRACT

OBJECT: The aim of this prospective study was to evaluate the phagocytic, humoral, and cellular arms of the immune system in comatose patients shortly after severe brain injury and to compare the findings with those reported earlier in patients in a persistent vegetative state. The study was conducted in intensive care units and immunology laboratories of university-affiliated hospitals in central Israel. METHODS: The study group consisted of 14 men aged 16 to 65 years who were comatose as a result of acute brain injury due to mechanical trauma. All were studied within 72 hours of injury. Brain damage was severe in all cases (Glasgow Coma Scale score < 8). Healthy age- and sex-matched volunteers served as simultaneous controls. Infections arose in nine (75%) of the 12 patients in whom data were available; the cumulative mortality rate was 38% (five of 13 patients in whom outcome data were available). Every patient exhibited one or more defects in at least one arm of the immune system. Significant deficiencies were noted in neutrophil superoxide release, immunoglobulin (Ig)G, IgG1, IgM, C1q, C2, properdin, alternate C pathway, T cells, T helper cells, T suppressor cells, and natural killer cells. In an earlier series of patients examined by the authors months after the primary insult, these impairments were absent in most of the patients in the vegetative state. CONCLUSIONS: Significant deficiencies of the immune system, particularly the cellular arm, are precipitated by severe brain injury within 72 hours of the event. These impairments probably play a role in the high rate of complicating infections and multiple organ failure. Together with earlier findings, the results of this study indicate that if brain-injured patients survive these hazards, their immune system will eventually recover.


Subject(s)
Brain Injuries/immunology , Coma/immunology , Neuroimmunomodulation/immunology , Adolescent , Adult , Aged , Chemotaxis, Leukocyte/immunology , Humans , Immunoglobulin G/blood , Male , Middle Aged , Neutrophils/immunology , Persistent Vegetative State/immunology , Phagocytosis/immunology , Prospective Studies , Respiratory Burst/immunology
3.
Psychother Psychosom Med Psychol ; 49(9-10): 337-42, 1999.
Article in German | MEDLINE | ID: mdl-10574000

ABSTRACT

The paper establishes a follow-up assessment procedure for inpatient psychotherapy. It is suited for more than one theoretical approach or specific disorder. Using data from a larger follow-up-study, those items are identified that show substantial correlations with health and resource oriented questionnaires. In a second analysis, items are selected that predict therapeutic effects on parameters of health-behavior. This pool of items has to be completed by items constructed by plausibility criteria.


Subject(s)
Inpatients , Psychophysiologic Disorders/rehabilitation , Psychotherapy , Surveys and Questionnaires/standards , Adult , Cross-Sectional Studies , Female , Follow-Up Studies , Germany , Health Status , Humans , Longitudinal Studies , Male , Mental Health , Psychiatric Status Rating Scales/standards , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...